PPARGC1A and type 2 diabetes mellitus: In our study, PPARGC1A was significantly downregulated in the type IIA myonuclei of the control group after the HIIT intervention, whereas in the diabetes group, it was downregulated in the type I myonuclei, again suggesting different response mechanisms to HIIT for individuals with type 2 diabetes.